All lobbying filings

FEROX STRATEGIES

Lobbying for VIATRIS INC · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate · $70,000.00 income · posted Jan 20, 2026

Official filing document

Bills named in this filing 1

S 1071
National Defense Authorization Act for Fiscal Year 2026

Lobbying activity 2

Trade (domestic/foreign)

Trade issues related to generic medicines.

Pharmacy

Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.